Biliary Cancer Completed Phase 2 Trials for Irinotecan (DB00762)

IndicationStatusPhase
DBCOND0038607 (Biliary Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00948935Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract AdenocarcinomaTreatment